Synlogic Inc (SYBX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

301 BINNEY STREET CAMBRIDGE, MA 02142

Synlogic, Inc. operates as a pharmaceutical company. The Company develops synthetic biotic medicines for inflammatory bowel diseases, cancer, metabolic diabetes, obesity, metabolic conditions, urea cycle disorders, and other rare genetic disorders. Synlogic serves customers in the United States.

Data as of 2021-05-08 11:42:00 -0400
Market Cap128.266 Million Shares Outstanding40.849 Million Avg 30-day Volume365.637 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-1.98 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.2655 52-week High/Low5.11 / 1.78 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from SYBX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 1 100.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 46 38 21.05% 17 (1.02%) 14 (0.87%) 21.43%
13F shares: 14.534 Million 13.789 Million 5.4% 5.715 Million 5.252 Million 8.82%
% Ownership 41.7242 39.5861 5.4% 16.4076 15.0773 8.82%
New Positions: 13 5 160.0% 4 1 300.0%
Increased Positions 15 3 400.0% 7 2 250.0%
Closed Positions 5 18 -72.22% 1 6 -83.33%
Reduced Positions 10 19 -47.37% 4 9 -55.56%
Total Calls 48.102 Thousand 27.3 Thousand 76.2% 24.5 Thousand
Total Puts 44.262 Thousand 3 1475300.0% 43.4 Thousand
PUT/CALL Ratio 0.92 0.0 1.77
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SYBX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SYBX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KHUONG CHAU QUANG

  • Director
3,696,662 2021-04-20 2

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

  • Director
3,696,662 2021-04-20 1

BRENNAN AOIFE SEE REMARKS

  • Officer
  • Director
462,317 2021-03-10 1

RIESE RICHARD J. CHIEF MEDICAL OFFICER

  • Officer
109,000 2021-03-10 1

AWAD ANTOINE CHIEF OPERATING OFFICER

  • Officer
113,000 2021-03-10 2

KELLY-CROSWELL LISA

  • Director
0 2021-02-09 2

BARRETT PETER

  • Director
0 2021-01-04 3

HEFFERNAN MICHAEL THOMAS

  • Director
0 2020-12-08 2

MATHERS EDWARD T

  • Director
0 2020-06-04 1

SHEA RICHARD P

  • Director
0 2020-06-04 1

LESCHLY NICK

  • Director
0 2020-06-04 1

HURTER PATRICIA N.

  • Director
0 2020-06-04 1

BURGESS MICHAEL F.

  • Director
0 2020-06-04 1

BELOFF GREGG SEE REMARKS

  • Officer
0 2019-10-23 0

PLEVY SCOTT ERIC CHIEF SCIENTIFIC OFFICER

  • Officer
8,000 2019-09-23 0

GINKGO BIOWORKS, INC.

  • 10% Owner
6,340,771 2019-06-11 0

POWELL MICHAEL

  • Director
0 2019-06-05 0

SHEGOG TODD SEE REMARKS

  • Officer
0 2019-03-05 0

MILLER PAUL FRANCIS CHIEF SCIENTIFIC OFFICER

  • Officer
48,135 2019-02-12 0

GUTIERREZ-RAMOS JOSE-CARLOS SEE REMARKS

  • Officer
  • Director
0 2018-03-14 0

GENGOS ANDREW CHIEF OPERATING OFFICER

  • Officer
0 2018-03-14 0

NEW ENTERPRISE ASSOCIATES 14, L.P.

NEA 14 GP, LTD

NEA PARTNERS 14, L.P.

  • 10% Owner
4,228,940 2018-01-26 0

BARRETT M JAMES

  • 10% Owner
4,228,940 2018-01-26 0

BARRIS PETER J

  • 10% Owner
4,228,940 2018-01-26 0

BASKETT FOREST

  • 10% Owner
4,228,940 2018-01-26 0

FLORENCE ANTHONY A. JR.

  • 10% Owner
4,228,940 2018-01-26 0

KERINS PATRICK J

  • 10% Owner
4,228,940 2018-01-26 0

MOTT DAVID M

  • 10% Owner
4,228,940 2018-01-26 0

SANDELL SCOTT D

  • 10% Owner
4,228,940 2018-01-26 0

SONSINI PETER W.

  • 10% Owner
4,228,940 2018-01-26 0

VISWANATHAN RAVI

  • 10% Owner
4,228,940 2018-01-26 0

ORBIMED ADVISORS LLC

ISALY SAMUEL D

ORBIMED CAPITAL GP VI LLC

  • Director
1,314,996 2017-08-28 0

ATLAS VENTURE FUND IX, L.P.

  • 10% Owner
2,651,963 2017-08-28 0

IRVIN JON VICE PRESIDENT, FINANCE

  • Officer
7,625 2016-12-01 0

ALLEVA LAWRENCE M

  • Director
0 2016-06-29 0

SIEGALL CLAY B

  • Director
0 2016-06-29 0

WINKLER MATTHEW

  • Director
0 2016-06-29 0

GREENLEAF PETER

  • Director
0 2016-06-29 0

NISEN PERRY

  • Director
0 2016-06-29 0

O'NEILL VINCENT CHIEF MEDICAL OFFICER

  • Officer
0 2016-04-25 0

DEYOUNG CASI CHIEF BUSINESS OFFICER

  • Officer
0 2016-03-11 0

FUHRMAN ALAN CHIEF FINANCIAL OFFICER

  • Officer
0 2016-03-11 0

LAMMERS PAUL PRESIDENT & CEO

  • Officer
  • Director
0 2016-03-11 0

SOFINNOVA VENTURE PARTNERS VIII, L.P.

SOFINNOVA MANAGEMENT VIII, L.L.C.

HEALY JAMES

AKKARAJU SRINIVAS

MEHRA ANAND

  • 10% Owner
2,974,811 2015-10-05 0

PFIZER INC

  • 10% Owner
2,489,364 2015-10-05 0

KOLLURI KRISHNA KITTU

  • 10% Owner
7,795,058 2015-10-05 0

WELLER HARRY R

  • 10% Owner
7,795,058 2015-10-05 0

NEW ENTERPRISE ASSOCIATES 14, L.P.

  • 10% Owner
2,971,517 2015-10-05 0

CANCER PREVENTION & RESEARCH INSTITUTE OF TEXAS

  • 10% Owner
2,395,010 2015-10-05 0

BARBOSA MIGUEL CHIEF SCIENTIFIC OFFICER

  • Officer
0 2015-09-30 0

JONES ELAINE V

  • Director
0 2015-09-30 0

KIM SINIL CHIEF MEDICAL OFFICER

  • Officer
0 2015-09-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

KHUONG CHAU QUANG - Director see footnotes

2021-04-22 17:11:02 -0400 2021-04-20 A 1,666,666 $3.00 a 3,696,662 indirect 1.0695 -6.6845 1.0695 2 -6.6845 6

ORBIMED ADVISORS LLC - Director see footnotes

ORBIMED CAPITAL GP VI LLC - Director see footnotes

2021-04-22 17:18:59 -0400 2021-04-20 A 1,666,666 $3.00 a 3,696,662 indirect 1.0695 -6.6845 1.0695 2 -6.6845 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SYNLOGIC INC SYBX 2021-05-10 22:15:04 UTC -1.1561 1.2061 1600000
SYNLOGIC INC SYBX 2021-05-10 21:45:02 UTC -1.1561 1.2061 1600000
SYNLOGIC INC SYBX 2021-05-10 21:15:02 UTC -1.1561 1.2061 1600000
SYNLOGIC INC SYBX 2021-05-10 20:45:03 UTC -1.1561 1.2061 1600000
SYNLOGIC INC SYBX 2021-05-10 20:15:03 UTC -1.1561 1.2061 1600000
SYNLOGIC INC SYBX 2021-05-10 19:45:03 UTC -1.1561 1.2061 1600000
SYNLOGIC INC SYBX 2021-05-10 19:15:03 UTC -1.1561 1.2061 1600000
SYNLOGIC INC SYBX 2021-05-10 18:45:03 UTC -1.1561 1.2061 1600000
SYNLOGIC INC SYBX 2021-05-10 18:15:03 UTC -1.1561 1.2061 1600000
SYNLOGIC INC SYBX 2021-05-10 17:45:02 UTC -1.1561 1.2061 1600000
SYNLOGIC INC SYBX 2021-05-10 17:15:03 UTC -1.1561 1.2061 1600000
SYNLOGIC INC SYBX 2021-05-10 16:45:03 UTC -1.1568 1.2068 1600000
SYNLOGIC INC SYBX 2021-05-10 16:15:03 UTC -1.1568 1.2068 1600000
SYNLOGIC INC SYBX 2021-05-10 15:45:03 UTC -1.1568 1.2068 1300000
SYNLOGIC INC SYBX 2021-05-10 15:15:03 UTC -1.1568 1.2068 1300000
SYNLOGIC INC SYBX 2021-05-10 14:45:04 UTC -1.3688 1.4188 1300000
SYNLOGIC INC SYBX 2021-05-10 14:15:04 UTC -1.3688 1.4188 1300000
SYNLOGIC INC SYBX 2021-05-10 13:45:04 UTC -1.3688 1.4188 1300000
SYNLOGIC INC SYBX 2021-05-10 13:15:03 UTC -1.3688 1.4188 1300000
SYNLOGIC INC SYBX 2021-05-10 12:45:02 UTC -1.3688 1.4188 1200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments